Create Medic (5187) Q4 2025 earnings summary

Executive summary

• Net sales for FY2025 increased by 4.5% year-over-year to ¥13,617 million, with operating profit rising 45.1% to ¥1,005 million.

• Profit attributable to owners of parent declined 15.1% year-over-year to ¥713 million.

• Comprehensive income for FY2025 was ¥988 million, down from ¥1,652 million in FY2024.

Financial highlights

• Ordinary profit rose 31.7% year-over-year to ¥1,091 million.

• Basic earnings per share for FY2025 was ¥84.25, down from ¥95.41 in FY2024.

• Total assets at year-end were ¥20,143 million, with net assets of ¥16,332 million.

• Cash and equivalents at year-end stood at ¥5,060 million.

• Cash flows from operating activities were ¥530 million, while investing and financing activities saw outflows of ¥573 million and ¥600 million, respectively.

Outlook and guidance

• FY2026 net sales are forecast to rise 2.5% year-over-year to ¥13,960 million.

• Operating profit is projected to increase 5.5% to ¥1,060 million, with profit attributable to owners of parent expected to grow 5.1% to ¥750 million.

• Basic earnings per share for FY2026 is forecast at ¥89.44.